FRANKFURT (Reuters) - Generics firm Alvogen is putting its Central and Eastern European (CEE) operations up for sale as its private equity owners seek a step-by-step exit from the maker of drugs ...

Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...

Summit-based Celgene Corp., Lotus Pharmaceutical Co., and Alvogen, headquartered in Pine Brook, (collectively, Alvogen) announced on Friday the settlement of their litigation relating to patents for ...

PINEBROOK, N.J.--(BUSINESS WIRE)--Alvogen, the international pharmaceuticals company announced today that it has acquired Dream Pharma (“Dream”) in South Korea for US$ 187 million in cash. Dream will ...

- Kevin Bain becomes EVP of Strategic Development and CFO of Alvotech PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen, today announced that Kevin Bain, the Company's Chief Financial Officer since 2009 will ...

In a battle over lethal execution drugs manufactured by pharma companies, 15 states have backed Nevada in a case alleging drugmaker Alvogen filed a meritless lawsuit only to delay an execution ...

MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the ...

Morristown-based Alvogen Inc. announced two lots of a transdermal patch used for delivery of the synthetic opioid Fentanyl have been recalled because the patches inside some cartons may contain a ...

Assertio said Dec. 12 it will sell its shingles pain drug, Gralise, to Alvogen for $127.5 million. Under the agreement, Alvogen will pay Assertio $75 million when the sale closes and the remainder as ...

Significant step towards Alvogen's ambition to be a top-5 business in Asia Pacific Region (APAC) Third significant acquisition in region since 2012, highlighting Alvogen's role as leading regional ...